Drugs in the blood Flashcards

1
Q

four stages of hemostasis and what happens during them

A

i. Vasospasm (vasoconstriction)
-Immediate; restricts blood flow
-Sympathetics and local factors eg. thromboxane
-Myogenic properties of vessel wall

ii. Platelet response
-Within seconds; forms initial plug
-Platelets adhere to exposed collagen of damaged endothelium, and each other
-Platelet plug releases chemical mediators (TXA2, 5-HT and ADP)
(recruit more platelets, promote vasoconstriction, initiate the coagulation cascade)

ii. Coagulation Phase
-Occurs thru sequential conversion of inactive proteins into catalytically active proteases
-Tissue factor-factor VIIa pathway is main initiator
-Result—conversion of soluble fibrinogen to insoluble fibrin—net of organized protein around platelet plug
-Result of coagulation phase is clot proper (thrombus)

iv. Clot dissolution (Fibrinolysis)
-Wound healing and restoration of blood flow
-Dissolution of clot by proteolytic actions of plasmin bound to clot process of fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 goals of normal hemostasis

A

§ Prevent prolonged hemorrhage
§ Prevent spontaneous thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

prothrombogenic factors (4)

A

Platelet Activators
Procoagulants
Vasoconstriction
Fibrinolytic Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

antithrombogenic factors (4)

A

Platelet Inhibitors
Anticoagulants
Vasodilators
Fibrinolytic Activators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

causes of excessive bleeding (3)

A

Platelet deficiency
-Thrombocytopenias (quantitative consumption)
-von Willebrand’s (qualitative disorder)

Clotting factor deficiency
-Single factor eg. hemophilia (VIII, IX)
-Multiple factors ie. vitamin K deficiency

Fibrinolytic hyperactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mechanism of action of Vitamin K for hemorrhagic diseases

A

Confers biological activity: factors II, VII, IX, X; post-translational modification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

forms of vitamin K

A

-Vitamin K1: phytonadione (foods)
-Vitamin K2: menaquinone (intestinal bacteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

uses of vitamin K

A

Vitamin K deficiency
-Rodenticide toxicity
-Dicumoral toxicity (sweet clover poisoning)

Warfarin overdosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

oral vs parenternal route of vitamin K administration

A
  • Intravenous route—best to avoid; anaphylaxis possible
  • IM route- hematoma possible; SC recommended route
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does vitamin K require for intestinal absorption

A

bile salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

desmopressin acetate (DDAVP); uses, how it works, forms

A
  • Transiently increases von Willebrand activity in mild von Willebrand disease
  • Used prophylactically to control capillary bleeding during surgery
    (Effects are short lived (2 hrs); repeat dosing—reduced effect)
  • Available as injectable or nasal spray (can be given SC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is protamine sulfate used for and how does it work

A

to treat heparin overdoses

-binds to heparin neutralizing its anticoagulant effects
-More effective against large molecular weight heparin molecules in unfractionated heparins versus the low molecular weight heparins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

two things to consider and why for administering protamine sulfate

A
  • Give IV slowly to avoid adverse reactions that can include collapse
  • Accurate dosing needed; high doses can produce anticoagulant
    effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how do fibrinolytic inhibitors work

A
  • Plasmin lyses fibrin and fibrinogen
    Attaches to fibrin via lysine binding sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is aminocaproic acid (amicar) used for and how does it work

A

-Synthetic agent similar to lysine; blocks lysine binding site
-Competitively inhibits plasmin action on fibrin
-Incomplete lysis can lead to thrombi formation

Uses
* Bleeding from fibrinolytic therapy
* Adjunct therapy-hemophiliacs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

three drug classes for thromboembolic disease

A

— Systemic anticoagulants
— Antithrombotic drugs
— Fibrinolytic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

venous vs arterial thrombus

A

-Red thrombus-fibrin rich, large # RBCs; venous
-White thrombus-platelet rich; arterial

17
Q

three prothrombic factors

A

-Local vessel injury
-Abnormal blood flow (stasis or turbulence)
-Altered blood coagulability (Hyperactivity of hemostatic mechanisms, Hypoactivity of fibrinolytic mechanisms)

18
Q

ideal systemic anticoagulant… (2)

A

-Prevent pathologic thrombosis
-Allow normal response to vascular injury and limit bleeding

19
Q

mechanism of action of heparin (unfractionated)

A

-Enhances (accelerates 100-fold) the action of Antithrombin III (AT-III)—forms heparin-ATIII complex

-AT- III inhibits activated clotting
factors especially thrombin (IIa) and
Xa—acts as a “suicide substrate”

20
Q

uses of heparin

A

Primarily used in the initial treatment of thrombosis and thromboembolic disease
—

-Rapid onset of action renders it useful as an “acute anticoagulant”
(Oral anticoagulant usually given concurrently)

-Prevents new thrombus formation only !! (Does not lyse existing thrombus)

21
Q

adverse effects of heparin

A

-Bleeding tendencies
-Monitor aPTT; 1.8-2.5X normal mean aPTT
-Protamine sulfate can neutralize heparin in overdose

22
Q

advantages of low molecular weight heparins (enoxaparin) compared to unfractionated heparin

A

-Less bleeding tendencies possible
-Protamine sulfate is less active against LMW heparins
-Less risk of thrombocytopenia
-Improved pharmacokinetics– can give subcutaneous

23
Q

adverse effects of warfarin

A

-Bleeding tendencies; can combat with Vitamin K1
-Serious bleeding requires fresh blood/plasma
-Warfarin crosses the placenta; don’t use in pregnancy; Heparin does not cross the placenta

24
how warfarin works
Oral anticoagulant by antagonizing vitamin K actions -Reduces clotting factors (II, VII, IX and X); factor VII has shortest half-life -Clotting not affected until existing factors used
25
what class is rivaroxaban
selective factor Xa inhibitors
26
how does rivaroxaban work
-Inactivate factor Xa directly -Does not interact with ATIII and no thrombin activity -Fairly quick anticoagulant activity
27
how does aspirin work
Irreversibly binds (acetylates) cyclooxygenase-1 -COX-1 selective over COX-2 at low doses; selectivity lost at higher doses -Prevents TXA2 production in platelets reducing platelet aggregation -Other NSAIDs can inhibit cyclooxygenase-1 but not irreversibly; hence a shorter duration of action -Cat metabolizes aspirin poorly; 2X weekly dosing used
28
uses of aspirin
-Feline cardiomyopathy -Heartworm disease -Equine laminitis and navicular diseases
29
adverse effects of aspirin
* Gastrointestinal ulceration * Renal damage * Bleeding tendencies
30
how does clopidogrel work
Reduce platelet aggregation by inhibiting ADP pathways -Act as P2Y 12 (aka P2YADP ) receptor antagonists; prevent binding of ADP to receptors -May be synergistic with aspirin as work by different mechanisms of action -Clopidogrel is irreversible inhibitor of the P2Y 12 receptor
31
what type of drug is clopidogrel
ADP inhibitor
32
what is clopidogrel used for
Clopidogrel is routinely used for thromboembolic concerns in cats (HCM) and in dogs (mainly IMHA)
33
how do fibrinolytic drugs work
Fibrinolytics rapidly lyse thrombi by activating plasmin from clot bound plasminogen
34
uses of tissue plasminogen activator
Thromboembolic therapy for canine pulmonary thromboembolism and feline saddle thrombis
35
adverse effects of of tissue plasminogen activator
* Reperfusion injury * Bleeding tendencies
36
how tissue plasminogen activator works
-Are proteases that bind fibrin -Can preferentially activate clot bound plasminogen (Limits activation of systemic plasmin) -Fairly short half-life necessitates constant rate infusion
37
adverse effects of EPO
* Hypertension and seizure possible * Therapeutic failure from antibody formation most common
38
how does EPO work
Glycoprotein made by kidney in response to hypoxia -Prepared by recombinant technology (rHuEPO) -EPO receptor is member of JAK/STAT superfamily -Stimulates proliferation differentiation of red cell progenitors and release of reticulocytes
39
use of EPO
* RhuEPO used primarily in chronic anemia due to erythropoietin production in Chronic renal failure * Has been used in anemia of other causes eg. Cancers
40
considerations when giving EPO
* Increase in hematocrit and hemoglobin in 2-4 weeks * Iron supplementation is advised with EPO therapy